Ying-xian Sun Selected Research

Dobutamine

2/2012

[Comparison on efficacy and safety between domestic levosimendan versus dobutamine for patients with acute decompensated heart failure].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying-xian Sun Research Topics

Disease

2	Hypertension (High Blood Pressure) 07/2011 - 07/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2010 - 08/2007
1	Lymphoma (Lymphomas) 04/2016
1	Pulmonary Arterial Hypertension 02/2013
1	Dyspnea (Shortness of Breath) 02/2012
1	Heart Failure 02/2012
1	Hypoxia (Hypoxemia) 02/2010
1	Reperfusion Injury 02/2010
1	Ischemia 08/2007
1	Stroke (Strokes) 02/2007
1	Chylous Ascites 01/2005

Drug/Important Bio-Agent (IBA)

2	Protein Kinase CIBA 02/2010 - 08/2007
1	Peptides (Polypeptides)IBA 04/2016
1	Member 2 Group C Nuclear Receptor Subfamily 2IBA 04/2016
1	transcription factor TFIIICIBA 04/2016
1	Transcription Factors (Transcription Factor)IBA 04/2016
1	Myc associated factor XIBA 04/2016
1	Methamphetamine (Desoxyn)FDA LinkGeneric 02/2013
1	Dobutamine FDA LinkGeneric 02/2012
1	Simendan (Levosimendan)IBA 02/2012
1	Glutathione PeroxidaseIBA 07/2011
1	Antihypertensive Agents (Antihypertensives)IBA 07/2010
1	bisindolylmaleimide IIBA 08/2007
1	Leu(15)- gastrin heptadecapeptideIBA 02/2007

Therapy/Procedure

1	Ischemic Postconditioning 08/2007
1	Therapeutics 01/2005